Lv S - Search Results

1

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

Yi K, Kong H, Zheng C, Zhuo C, Jin Y, Zhong Q, Mintz RL, Ju E, Wang H, Lv S, Lao YH, Tao Y, Li M. Yi K, et al. Among authors: lv s. Biomaterials. 2023 Nov;302:122349. doi: 10.1016/j.biomaterials.2023.122349. Epub 2023 Oct 6. Biomaterials. 2023. PMID: 37844429

2

Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.

Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X. Lv S, et al. Acta Biomater. 2013 Dec;9(12):9330-42. doi: 10.1016/j.actbio.2013.08.015. Epub 2013 Aug 17. Acta Biomater. 2013. PMID: 23958784

3

Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.

Song W, Tang Z, Li M, Lv S, Sun H, Deng M, Liu H, Chen X. Song W, et al. Among authors: lv s. Acta Biomater. 2014 Mar;10(3):1392-402. doi: 10.1016/j.actbio.2013.11.026. Epub 2013 Dec 6. Acta Biomater. 2014. PMID: 24316362

4

Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin.

Song W, Tang Z, Zhang D, Zhang Y, Yu H, Li M, Lv S, Sun H, Deng M, Chen X. Song W, et al. Among authors: lv s. Biomaterials. 2014 Mar;35(9):3005-14. doi: 10.1016/j.biomaterials.2013.12.018. Epub 2014 Jan 2. Biomaterials. 2014. PMID: 24388813

5

Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.

Li M, Tang Z, Lv S, Song W, Hong H, Jing X, Zhang Y, Chen X. Li M, et al. Among authors: lv s. Biomaterials. 2014 Apr;35(12):3851-64. doi: 10.1016/j.biomaterials.2014.01.018. Epub 2014 Feb 1. Biomaterials. 2014. PMID: 24495487

6

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.

Lv S, Tang Z, Li M, Lin J, Song W, Liu H, Huang Y, Zhang Y, Chen X. Lv S, et al. Biomaterials. 2014 Jul;35(23):6118-29. doi: 10.1016/j.biomaterials.2014.04.034. Epub 2014 May 1. Biomaterials. 2014. PMID: 24794923

7

Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.

Li M, Tang Z, Zhang Y, Lv S, Li Q, Chen X. Li M, et al. Among authors: lv s. Acta Biomater. 2015 May;18:132-43. doi: 10.1016/j.actbio.2015.02.022. Epub 2015 Feb 28. Acta Biomater. 2015. PMID: 25735801

8

PEG-polypeptide conjugated with LHRH as an efficient vehicle for targeted delivery of doxorubicin to breast cancer.

Lv S, Tang Z, Li M, Song W, Chen X. Lv S, et al. J Control Release. 2015 Sep 10;213:e99. doi: 10.1016/j.jconrel.2015.05.165. Epub 2015 Aug 19. J Control Release. 2015. PMID: 27005267 No abstract available.

9

Inhibiting Solid Tumor Growth In Vivo by Non-Tumor-Penetrating Nanomedicine.

Lv S, Tang Z, Song W, Zhang D, Li M, Liu H, Cheng J, Zhong W, Chen X. Lv S, et al. Small. 2017 Mar;13(12). doi: 10.1002/smll.201600954. Epub 2017 Jan 12. Small. 2017. PMID: 28079981

10

Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury.

Guan Y, Yao W, Yi K, Zheng C, Lv S, Tao Y, Hei Z, Li M. Guan Y, et al. Among authors: lv s. Small. 2021 Jun;17(23):e2007727. doi: 10.1002/smll.202007727. Epub 2021 Apr 14. Small. 2021. PMID: 33852769 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,393 results

Search Page

Filters